Latest / JIJI English News-時事通信英語ニュース-
Japan OKs Insurance Coverage of Alzheimer's Drug Lecanemab Injection
An advisory panel to Japan's health minister approved Friday public health insurance coverage for an injection version of lecanemab, an Alzheimer's medicine developed by Eisai Co. and Biogen Inc., and its administration at patients' homes, effective on Nov. 13.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.